Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 14888 clinical trials
Immune Response and Risk of Serious Infection to SARS-Cov2

The objective of this study is to measure the intensity of the T lymphocyte response in patients hospitalized for Cov2 SARS infection in order to determine whether the intensity of the response is associated with worsening of symptoms.

  • 0 views
  • 16 Feb, 2024
  • 1 location
Occurrence of Antibodies Cross-reacting With Autoantigens in Primary EBV Infection

Procalcitonin (PCT) concentrations in primary EBV infection compared to control patients with similar symptoms and its association with disease severity and local complications. the occurrence of fatigue and symptoms associated with chronic fatigue syndrome 6 and 12 months after primary EBV infection.

  • 0 views
  • 22 Nov, 2021
  • 2 locations
Quality of Life and Physical Performance After Novel Coronavirus Infection (COVID-19);

This study aims to observe the long-term health-related quality of life (HRQOL) and physical performance in individuals hospitalized due to a COVID-19 infection. Therefore, data is extracted from a study-site standard aftercare program which has been adjusted for this patient population.

  • 0 views
  • 05 Aug, 2020
Viral Excretion in Contact Subjects at High/Moderate Risk of Coronavirus 2019-nCoV Infection. COVID-19.

Whether such subjects become spreaders of the virus is not known, nor is the proportion of viral spreader who will develop a symptomatic infection.

pneumonia
SARS
coronavirus infection
acute respiratory syndrome (sars)
covid-19
  • 0 views
  • 16 Feb, 2024
  • 17 locations
Immunoglobulin G Antibody Immune Response Profile Following Infection With SARS-CoV-2 in COVID-19 Egyptian Patients

The objective of this study is to detect the evidence on the immune response following acute SARS-CoV-2 infections. the study will report the profile of IgG specific antibodies levels to SARS-CoV-2 infection found in recovered coronavirus disease (COVID-19) patients after infection for both symptomatic and asymptomatic patients.

coronavirus infection
acute respiratory syndrome (sars)
SARS
immunoglobulins
  • 0 views
  • 05 Aug, 2020
Impact of a Carrier (Infection Colonization) of Highly Bacteria Resistance on the Patient's Quality of Life Hospital Environment

The quality of life of carriers detected infected or colonized by emerging highly resistant bacteria (BHRe) following the implementation of specific hygiene measures during the discovery of the microorganism has been little studied. To date, there have been no studies to determine the quality of life (QoL) in France of …

  • 0 views
  • 16 Feb, 2024
  • 1 location
Construct Validation of the BIOTICA Questionnaire

Based on barriers identified in a systematic literature search, a self-report questionnaire called "BIOTICA" has been developed by the research team to assess medication adherence barriers to oral AB. The purpose of the BIOTICA-questionnaire is to detect individual barriers that prevent the optimal intake of oral AB and thus, lead …

antibiotic therapy
antibiotics
  • 0 views
  • 16 Feb, 2024
  • 1 location
COVID-19 - Multicenter Study on Nosocomial Transmission of SARS-CoV-2 Virus

The risk of infection with SARS-CoV-2 during hospitalization is also substantial and increased in fragile patients. Several cases of infection among Healthcare Professionals had been reported.

pharyngeal pain
coronavirus
covid-19
acute respiratory syndrome (sars)
nosocomial infection
  • 0 views
  • 16 Feb, 2024
  • 1 location
Anti-SARS-CoV-2 Inactivated Convalescent Plasma in the Treatment of COVID-19

There is still no effective antiviral drugs and vaccines against SARS-CoV-2 yet now. This is an obsevational study, the investigators collected the clinical information and clinical outcomes of the COVID-19 patients using anti-2019-nCoV inactivated convalescent plasma.The study is to evaluate the efficacy and safety of anti-2019-nCoV inactivated convalescent plasma in …

antiviral drugs
SARS
pneumonia
acute respiratory syndrome (sars)
covid-19
  • 0 views
  • 16 Feb, 2024
  • 1 location
The CASCADE Study - Measures of Complement Activation and Inflammation in Patients With Covid-19

COVID-19 is a new disease and therefore it is still not clear exactly how the virus affects the body and why people are affected so differently. It causes infection in the lungs and the virus can then attack blood vessels in the lungs and other organs to spark off an …

covid-19
inflammatory response
  • 0 views
  • 16 Feb, 2024
  • 1 location